Gene · 112398
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System. | Cancers (Basel) | 2023 | 37760571 | PubTator, text mining | PubMed |
| Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization. | Clin Proteomics | 2023 | 37749499 | PubTator, text mining | PubMed |
| Börjeson-Forssman-Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families. | Eur J Hum Genet | 2023 | 37704779 | PubTator, text mining | PubMed |
| Potential targets of natural medicines: preventing lung cancer pre-metastatic niche formation by regulating exosomes. | Front Oncol | 2023 | 37700835 | PubTator, text mining | PubMed |
| Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. | Cancers (Basel) | 2023 | 37686693 | PubTator, text mining | PubMed |
| Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis. | Nature | 2023 | 37674080 | PubTator, text mining | PubMed |
| Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress. | Neuroprotection | 2023 | 37671067 | PubTator, text mining | PubMed |
| A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress. | EMBO J | 2023 | 37661833 | PubTator, text mining | PubMed |
| FBXW7 in breast cancer: mechanism of action and therapeutic potential. | J Exp Clin Cancer Res | 2023 | 37658431 | PubTator, text mining | PubMed |
| Microscopic Raman study of fungal pigment using the genetically amenable rock inhabitant Knufia petricola as a model organism. | Spectrochim Acta A Mol Biomol Spectrosc | 2023 | 37625274 | PubTator, text mining | PubMed |
| Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. | J Biomed Sci | 2023 | 37605155 | PubTator, text mining | PubMed |
| Hypoxia-driven ncRNAs in breast cancer. | Front Oncol | 2023 | 37583933 | PubTator, text mining | PubMed |
| CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577230 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications. | Heliyon | 2023 | 37560684 | PubTator, text mining | PubMed |
| REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial. | Mol Cancer | 2023 | 37559050 | PubTator, text mining | PubMed |
| COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcome. | J Transl Med | 2023 | 37553713 | PubTator, text mining | PubMed |
| Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson's disease model. | Cell Biosci | 2023 | 37528492 | PubTator, text mining | PubMed |
| Intracellular energy production and distribution in hypoxia. | J Biol Chem | 2023 | 37507013 | PubTator, text mining | PubMed |
| Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. | Exp Hematol Oncol | 2023 | 37501213 | PubTator, text mining | PubMed |
| Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. | Int J Biol Sci | 2023 | 37497000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/112398/papers?page=7